Go Deep
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -29,585 | -96.6 | -32.59 | -4.00 | 6,249.27 |
| Oct 2026 | -15,338 | -96.8 | -31.70 | -13.19 | 6,023.99 |
| Oct 2026 | -47,403 | -92.2 | -30.24 | -13.19 | 5,706.40 |
| Oct 2026 | -47,326 | -91.8 | -30.12 | -13.19 | 5,665.52 |
| Oct 2026 | -47,734 | -93.8 | -30.78 | -13.19 | 5,791.67 |
| Oct 2026 | -47,193 | -91.1 | -29.90 | -13.19 | 5,610.91 |
| Oct 2026 | -47,900 | -94.7 | -31.05 | -13.19 | 5,834.05 |
| Oct 2026 | -48,330 | -96.8 | -31.76 | -13.19 | 5,965.85 |
| Oct 2026 | -48,234 | -93.5 | -31.61 | -13.19 | 5,922.74 |
| Oct 2026 | -48,367 | -97.0 | -31.82 | -13.19 | 5,950.40 |
PTC Therapeutics, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 360,519,000.0 | 272,551,000.0 | 164,677,000.0 | 211,007,000.0 |
| Net Profit | 83,496,000.0 | -2,809,000.0 | -134,965,000.0 | 15,896,000.0 |
| EPS | 1.0 | -0.0 | -1.7 | 0.2 |
PTC Therapeutics, Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 1,730,655,000.0 | 806,780,000.0 | 937,822,000.0 | 698,801,000.0 |
| Net Profit | 682,644,000.0 | -363,295,000.0 | -626,604,000.0 | -559,017,000.0 |
| EPS | 8.6 | -4.7 | -8.4 | -7.8 |
PTC Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 2,898,767,000.0 | 1,705,024,000.0 | 1,895,698,000.0 | 1,705,619,000.0 | — |
| Total Liabilities | 3,104,080,000.0 | 2,803,095,000.0 | 2,714,253,000.0 | 2,052,705,000.0 | — |
| Total Equity | -205,313,000.0 | -1,098,071,000.0 | -818,555,000.0 | -347,086,000.0 | — |
Owes vs Owns
PTC Therapeutics, Inc. owed $1.05 for every $1 it owned in Jun 2026, down from $1.20 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.05× | 1.07× | 1.64× | 1.43× | 1.20× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
PTC Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 67.1%Receivables 6.3%Inventory 2.7%Fixed assets (tangible) 4.7%Intangible assets 16.3%Other assets 3.0%
How it's funded — Dec 2025
Short-term debt 18.4%Long-term debt 65.2%Payables 1.5%Other liabilities 14.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,945.4 | 1,139.7 | 876.7 | 410.7 |
| Receivables | 181.6 | 158.6 | 160.8 | 155.6 |
| Inventory | 79.6 | 23.2 | 30.6 | 21.8 |
| Fixed assets (tangible) | 135.4 | 117.7 | 179.0 | 175.0 |
| Intangible assets | 471.1 | 201.1 | 461.8 | 788.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 85.6 | 64.8 | 186.7 | 154.2 |
| Liabilities & equity | ||||
| Short-term debt | 569.6 | 257.8 | 194.3 | 72.1 |
| Long-term debt | 2,025.4 | 2,109.4 | 1,904.0 | 1,257.5 |
| Payables | 45.5 | 17.3 | 6.0 | 27.3 |
| Other liabilities | 463.6 | 418.6 | 609.9 | 695.8 |
| Shareholders' equity | -205.3 | -1,098.1 | -818.6 | -347.1 |
| Net tangible assets | -676.4 | -1,299.2 | -1,280.4 | -1,135.3 |
PTC Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 711,196,000.0 | -107,688,000.0 | -158,418,000.0 | -356,654,000.0 | — |
| Investing Activities | -861,984,000.0 | 44,182,000.0 | -176,737,000.0 | 290,181,000.0 | — |
| Financing Activities | 331,094,000.0 | 255,866,000.0 | 646,400,000.0 | 167,952,000.0 | — |